Diagnostics and research stocks cheapest against their own PE history
Where today's PE sits among every trading day of the company's last ten years: 0 is its cheapest day, 100 its dearest. As of .
- Ranked
- 15
- of 74 diagnostics and research stocks we cover
- Median
- 65th pct
- Lowest
- 20th pct
- IDXX
- Range
- 20th pct to 100th pct
median 65th pct
20th pct100th pct
| # | Company | PE vs its 10 years | PE | Its 10y median PE | Market cap |
|---|---|---|---|---|---|
| 1 | IDXXIDEXX Laboratories | 20th pct | 46.5× | 54.9× | $52.1B |
| 2 | ILMNIllumina | 31st pct | 44.0× | 51.3× | $35.7B |
| 3 | IQVIQVIA | 39th pct | 32.0× | 34.8× | $42.5B |
| 4 | LNTHLantheus | 53rd pct | 24.3× | 24.0× | $6.5B |
| 5 | BIOBio-Rad Laboratories | 54th pct | 44.4× | 30.9× | $9.8B |
| 6 | AAgilent Technologies | 56th pct | 34.5× | 33.2× | $49.6B |
| 7 | MTDMettler-Toledo International | 57th pct | 38.4× | 36.6× | $34.2B |
| 8 | DHRDanaher | 65th pct | 37.9× | 34.3× | $162.6B |
| 9 | TMOThermo Fisher Scientific | 68th pct | 36.7× | 33.1× | $256.9B |
| 10 | LHLabcorp | 79th pct | 29.4× | 19.5× | $28.9B |
| 11 | ICCCImmucell | 87th pct | 132× | 44.1× | $95.9M |
| 12 | RVTYRevvity | 90th pct | 72.2× | 35.1× | $16.9B |
| 13 | WATWaters | 93rd pct | 118× | 29.2× | $46.4B |
| 14 | DGXQuest Diagnostics | 98th pct | 24.9× | 19.3× | $27.5B |
| 15 | NRCNRC Health | 100th pct | 97.0× | 35.2× | $536.6M |
Not ranked: 51 with no PE (losses over the last year), 3 with under ten years of history. 5 companies whose data behind this number has a caveat are left out until it is checked.
A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.
PE vs its 10 years for other groups
Other rankings of diagnostics and research stocks
- Diagnostics and research stocks with the lowest PE ratio
- Diagnostics and research stocks with the lowest price to sales ratio
- Diagnostics and research stocks with the lowest EV/EBIT
- Diagnostics and research stocks with the highest free cash flow yield
- Diagnostics and research stocks with the fastest revenue growth
- Diagnostics and research stocks with the fastest expected revenue growth
- Diagnostics and research stocks with the fastest earnings growth
- Diagnostics and research stocks with the highest profit margins